Arcus Biosciences Completes Public Offering of Common Stock
Bacaan kurang dari 1 minit
On November 3, 2025, Arcus Biosciences announced the completion of its public offering, raising approximately $269.7 million.
Key Highlights:
- Arcus sold 15,755,000 shares at $18.25 each.
- Underwriters exercised their option for an additional 2,055,000 shares.
- Net proceeds of $269.7 million were raised after expenses.
- Offering was made under an effective Form S-3 registration.
Original SEC Filing: Arcus Biosciences, Inc. [ RCUS ] - 8-K - Nov. 03, 2025
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.